A study by Borger et al. of 18 patients with IDH1-mutated intrahepatic cholangiocarcinoma showed a sensitivity of 83% and a specificity of 90% at a cutoff of 2HG serum levels ≥1.15 mmol/L [48]. This evidence concerns the gene IDH1 and intrahepatic cholangiocarcinoma.